Literature DB >> 6404270

Recombinant gamma interferon enhances natural killer cell activity similar to natural gamma interferon.

D A Weigent, G J Stanton, H M Johnson.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6404270     DOI： 10.1016/0006-291x(83)90338-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  9 in total

Review 1.  Interferons 1992. How much of the promise has been realised?

Authors:  M A Volz; C H Kirkpatrick
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

2.  Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma.

Authors:  F Farace; C Mathiot; M Brandely; T Tursz; T Dorval; P Pouillart; F Triebel; T Hercend; W H Fridman
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

3.  Immunological memory induced by genetically transduced tumor cells.

Authors:  M M Dar; Z Abdel-Wahab; C E Vervaert; T Darrow; J Barber; H F Seigler
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

4.  Mechanisms of macrophage activation in rheumatoid arthritis: the role of gamma-interferon.

Authors:  M G Ridley; G S Panayi; N S Nicholas; J Murphy
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

5.  Enhanced interferon-gamma (IFN) production by lymph node cells from autoimmune (MRL/1, MRL/n) mice.

Authors:  N Manolios; L Schrieber; M Nelson; C L Geczy
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

6.  Subcutaneous recombinant gamma interferon in cancer patients: toxicity, pharmacokinetics, and immunomodulatory effects.

Authors:  J A Thompson; W W Cox; C G Lindgren; C Collins; K A Neraas; E M Bonnem; A Fefer
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

7.  Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity.

Authors:  Y Watanabe; K Kuribayashi; S Miyatake; K Nishihara; E Nakayama; T Taniyama; T Sakata
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Production of multiple cytokines by clones of human large granular lymphocytes.

Authors:  P Allavena; G Scala; J Y Djeu; A D Procopio; J J Oppenheim; R B Herberman; J R Ortaldo
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

Review 9.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.